View larger
LARS1 antibody
FT-FNab04701
New product
100 µg
Ao comprar este produto pode ganhar até 2 pontos de fidelização. Seu carrinho totalizará 2 pontos de fidelização que podem ser convertidos num vale de desconto de 8.00EUR.
Data sheet
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC, IF, IP |
| Target | LARS1 |
| Research Area | Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | leucyl-tRNA synthetase |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Leucine--tRNA ligase, cytoplasmic|Leucyl-tRNA synthetase (LeuRS, cLRS)|LARS1|KIAA1352|LARS |
| Host | Rabbit |
| UniProt ID | Q9P2J5 |
| Gene ID | 51520 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 135-140 kDa |
| Background | Catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid(AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Exhibits a post-transfer editing activity to h |
More info
LARS antibody